指南与共识儿科与产科急症重症综合管理与镇静镇痛

胎盘植入谱系产前诊断与分类:世界围产医学协会与围产医学基金会临床实践指南与推荐

Antenatal diagnosis and classification for placenta accreta (adherence) spectrum: Clinical practice guideline and recommendations by the World Association of Perinatal Medicine and the Perinatal Medicine Foundation.
指南 / 共识 · Pregnancy (Hoboken) · 2026-10-24
一句话结论对既往剖宫产孕妇应早期经阴道超声确定着床部位、识别剖宫产瘢痕妊娠,疑似胎盘植入谱系应转诊至具备多学科团队的围产中心。

该实践指南由世界围产医学协会与围产医学基金会制定,旨在支持胎盘植入谱系(PAS)风险妊娠的产前诊断与临床管理,提供筛查、诊断、转诊和围产期计划的循证方法。PAS与严重母体并发症相关,包括大出血、大量输血、子宫破裂、围产期子宫切除、盆腔器官损伤、ICU入住和孕产妇死亡。剖宫产瘢痕妊娠被认为是PAS的潜在前驱病变,既往剖宫产且低着床部位者风险增加,建议早期经阴道超声确定着床部位。中晚孕期联合经腹与经阴道超声评估胎盘位置、肌层厚度和轮廓及子宫膀胱界面,二维灰阶超声是产前评估的主要手段,彩色多普勒辅助,MRI在超声不确定时起补充作用。疑似CSP或PAS应转诊至具备多学科专长、血液制品支持、成人及新生儿重症监护和复杂盆腔手术能力的围产中心。

要点

  • 既往剖宫产孕妇建议早期经阴道超声确定着床部位、识别剖宫产瘢痕妊娠并支持咨询和及时考虑保留子宫的治疗。
  • 中晚孕期联合经腹与经阴道超声评估胎盘位置、肌层厚度和轮廓及子宫膀胱界面,二维灰阶超声是产前评估的主要手段。
  • 超声标志物包括胎盘陷窝、胎盘膨隆、子宫膀胱区血供过多和桥接血管,可单独或组合出现。
  • MRI在超声不确定、胎盘位置非前壁或非前置、或技术因素限制显像时起补充作用。
  • 疑似CSP或PAS应转诊至具备多学科专长、血液制品支持、成人及新生儿重症监护和复杂盆腔手术能力的围产中心。

适用人群与场景

  • 既往剖宫产且低着床部位的孕妇PAS风险增加。
  • 剖宫产瘢痕妊娠被认为是PAS的潜在前驱病变。
  • 适用于不同资源医疗机构的PAS风险妊娠的产前筛查、诊断、转诊和围产期计划。

处置流程与药物剂量

  • 既往剖宫产孕妇建议早期经阴道超声确定着床部位、识别CSP并支持咨询和及时考虑保留子宫的治疗。
  • 中晚孕期联合经腹与经阴道超声评估胎盘位置、肌层厚度和轮廓及子宫膀胱界面。
  • 二维灰阶超声是产前评估的主要手段,彩色多普勒辅助;三维成像可在选定的专科机构提供额外信息。
  • MRI在超声不确定、胎盘位置非前壁或非前置、或技术因素限制显像时起补充作用。
  • 疑似CSP或PAS应转诊至具备多学科专长、血液制品支持、成人及新生儿重症监护和复杂盆腔手术能力的围产中心。
  • 分娩时机和手术准备应个体化。

红旗征与不能漏的情况

  • PAS与严重母体并发症相关,包括大出血、大量输血、子宫破裂、围产期子宫切除、盆腔器官损伤、ICU入住和孕产妇死亡。

证据类型、等级与局限

  • 证据类型:世界围产医学协会与围产医学基金会临床实践指南与推荐。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 对既往剖宫产孕妇,应在早期以经阴道超声确定着床部位并识别CSP,以支持咨询和及时考虑保留子宫的治疗。
  • 中晚孕期应以二维灰阶超声联合经腹与经阴道途径评估胎盘位置、肌层厚度和轮廓及子宫膀胱界面,彩色多普勒辅助,三维成像仅在选定专科机构提供额外信息。
  • 超声不确定、胎盘位置非前壁或非前置、或技术因素限制显像时,应使用MRI作为补充。
  • 疑似CSP或PAS应转诊至具备多学科专长、血液制品支持、成人及新生儿重症监护和复杂盆腔手术能力的围产中心。
  • 分娩时机和手术准备应个体化。

指南或共识出处

  • 世界围产医学协会与围产医学基金会临床实践指南与推荐(Pregnancy (Hoboken))

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「研究设计与关键结果」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

This practical guidance was developed by the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation to support antenatal diagnosis and clinical management in pregnancies at risk for placenta accreta spectrum (PAS). It provides an evidence-informed approach to screening, diagnosis, referral, and peripartum planning across healthcare settings with different resources. PAS is increasingly encountered alongside rising cesarean delivery rates, use of in vitro fertilization, and a history of uterine surgery. It remains associated with severe maternal morbidity, including massive hemorrhage, large-volume transfusion, uterine rupture, peripartum hysterectomy, pelvic organ injury, intensive care admission, and maternal death. Early recognition and multidisciplinary care are therefore central to management. Cesarean scar pregnancy (CSP) is considered a potential precursor of PAS. Women with a low implantation site and a previous cesarean delivery are at increased risk. Early transvaginal ultrasound is advised in women with a previous cesarean delivery to establish the implantation site, identify CSP, and support counseling and timely consideration of uterine-preserving treatment. In the second and third trimesters, combined transabdominal and transvaginal ultrasound assesses placental location, myometrial thickness and contour, and the uterovesical interface. Sonographic markers include placental lacunae, placental bulge, uterovesical hypervascularity, and bridging vessels, which may occur individually or in combination. Two-dimensional grayscale ultrasound is the mainstay of antenatal assessment, supported by color Doppler; three-dimensional imaging may provide additional information in selected specialist settings. Magnetic resonance imaging has a complementary role when ultrasound is inconclusive, placental location is non-anterior or non-previa, or technical factors limit visualization. Suspected CSP or PAS should prompt referral to a perinatal center with multidisciplinary expertise, blood product support, adult and neonatal intensive care, and access to complex pelvic surgery. Delivery timing and surgical preparation should be individualized.

来源:Pregnancy (Hoboken),查看原文。版权归原作者所有。

参考来源

  1. Dall'Asta A, Sen C, Aryananda R, et al. Antenatal diagnosis and classification for placenta accreta (adherence) spectrum: Clinical practice guideline and recommendations by the World Association of Perinatal Medicine and the Perinatal Medicine Foundation. Pregnancy (Hoboken). 2026. PMID: 42927239. doi:10.1002/pmf2.70489

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。